Skip to content

Using the DUCK score to decide whether to crosslink

Question  Can adhering to the Dutch Crosslinking for Keratoconus (DUCK) score improve clinical decision making in patients with progressive keratoconus? Findings  This cohort study of 504 eyes and 388 patients found that adhering to the DUCK score was associated with a reduction in the overall crosslinking treatment rate without increasing the risk of disease progression.

Read More

Keratoconus: A family affair

Clinicians should screen close relatives of their patients with the condition. New data adds more weight to the theory that keratoconus is driven, in part, by genetics. Read more

Keratoconus: a French view

Listen to two French keratoconus experts discuss the latest treatments for this corneal disease and the evidence to support their use in this podcast from the The European Society of Cataract & Refractive Surgeons (ESCRS).

Why you are paying so much for surgery

ABC Four Corners produced this program Mind the Gap on why you are paying such high out-of-pocket expenses for surgery. A great guide to dealing with surgeons before surgery. Watch the program

Medicare rebate for corneal cross-linking

Thousands of Australians with keratoconus will benefit from a Medicare rebate of $1,200 for corneal collagen cross-linking as first line treatment to stop disease progression. read more    

First results from Australian Crosslinking Registry

The head of the Australian Crosslinking Registry, Professor Stephanie Watson, presented the latest results from the registry on crosslinking at meetings in Melbourne and Sydney. The full video of her presentation can be viewed here Her slideshow presentation (pdf format) can be downloaded below Professor Watson Nov 2017 talk

Cross-linking stabilises keratoconus

Optometry Australia News   Collagen corneal cross-linking appears to stabilise keratoconus in patients who undergo the procedure, according to early results of a world-first keratoconus registry based in Australia. Ophthalmologist Professor Stephanie Watson has completed initial analysis of data from 1,062 keratoconic patients in Australia and New Zealand including adults, teenagers and children who had

Read More